Investor Notice: Robbins LLP Informs Investors of Class Action Filed Against AlloVir, Inc. (ALVR)
22 janv. 2024 21h09 HE
|
Robbins LLP
AlloVir, Inc. (ALVR) Allegedly Misled Investors Regarding Efficacy of its posoleucel Phase 3 Studies
Allogene Therapeutics, Inc. Investors: Company Investigated by the Portnoy Law Firm
11 oct. 2021 19h52 HE
|
Portnoy Law
LOS ANGELES, Oct. 11, 2021 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Allogene Therapeutics, Inc. ("Therapeutics" or the "Company") (NASDAQ: ALLO) investors that the firm has initiated an...